United States
US 12,697,384 B2
Multiple antigenic peptide against corona virus and immunostimulating composition containing the same
US 12,697,384 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: ANIMAL ALLERGY CLINICAL LABORATORIES INC.; RIKEN. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- ANIMAL ALLERGY CLINICAL LABORATORIES INC.; RIKEN
- Inventors
- Kenichi MASUDA; Takashi SAITO
- Publication date
- 2026-08-04
- Filing date
- 2022-11-21
- Document type
- B2 Granted patent
- Also written as
- US 12,697,384 B2 · US12697384 · 12697384
Abstract
The present invention provides a vaccine against a coronavirus. According to the present invention, there is provided a peptide consisting of the amino acid sequence set forth in SEQ ID NO: 1 or a partial peptide of a coronavirus spike protein consisting of the amino acid sequence corresponding to the amino acid sequence of SEQ ID NO: 1 and a multiple antigen peptide containing a plurality of any of these peptides.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free